-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Protagenic Therapeutics, Inc.\new quarterly/annual Depreciation history and growth rate from Q1 2016 to Q3 2024.
- Protagenic Therapeutics, Inc.\new Depreciation for the quarter ending September 30, 2024 was $12.6K, a 786% increase year-over-year.
- Protagenic Therapeutics, Inc.\new Depreciation for the twelve months ending September 30, 2024 was $64.3K.
- Protagenic Therapeutics, Inc.\new annual Depreciation for 2023 was $28.2K, a 93960% increase from 2022.
- Protagenic Therapeutics, Inc.\new annual Depreciation for 2022 was $30.000.
- Protagenic Therapeutics, Inc.\new annual Depreciation for 2020 was $286.000, a 15.6% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)